Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients

2008/09/28 by Kwang Kon Koh, Michael J. Quon, Seung Hwan Han +5 · 20 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Adipokines, Inflammation, and Metabolic Diseases #Adiponectin #Cancer, Lipids, and Metabolism #Cholesterol #Endocrinology #Insulin #Insulin resistance #Internal medicine #Lipoproteins and Cardiovascular Health #Medicine #Placebo #Pravastatin #Simvastatin

paper · doi:10.1016/j.atherosclerosis.2008.09.021

openalex publication_date 2008/09/28 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. [europepmc]
• Alternative macrophage activation and metabolism. [europepmc]
• Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. [europepmc]
• Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. [europepmc]
• Cardiovascular Risk in Women With PCOS. [europepmc]
• Differential metabolic actions of specific statins: clinical and therapeutic considerations. [europepmc]
• Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy? [europepmc]
• An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials. [europepmc]
• Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials. [europepmc]
• The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome. [europepmc]
• Effects of Pravastatin on Type 1 Diabetic Rat Heart with or without Blood Glycemic Control. [europepmc]
• Simvastatin-Induced Insulin Resistance May Be Linked to Decreased Lipid Uptake and Lipid Synthesis in Human Skeletal Muscle: the LIFESTAT Study. [europepmc]
• Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials. [europepmc]
• Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. [europepmc]
• Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice. [europepmc]
• Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan. [europepmc]
• Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis. [europepmc]
• Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments. [europepmc]
• Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. [europepmc]
• Pravastatin for lowering lipids. [europepmc]